Development of orodispersible polymer films with focus on the solid state characterization of crystalline loperamide

被引:32
作者
Woertz, Christina [1 ]
Kleinebudde, Peter [1 ]
机构
[1] Univ Dusseldorf, Inst Pharmaceut & Biopharmaceut, D-40225 Dusseldorf, Germany
关键词
Orodispersible films; Polymer; Loperamide hydrochloride; Polymorph; Crystallinity; HPMC; HPC; Tragacanth; IN-VIVO EVALUATION; MUCOADHESIVE PATCHES; MOLECULAR-CRYSTALS; DOSAGE FORMS; LIDOCAINE; VITRO; PHARMACEUTICALS; POLYMORPHISM; BCS;
D O I
10.1016/j.ejpb.2015.04.036
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The formulation of active pharmaceutical ingredients (API) as orodispersible films is gaining interest among novel oral drug delivery systems due to their small size, enhanced flexibility and improved patient compliance. The aim of this work was the preparation and characterization of orodispersible films containing loperamide hydrochloride (LPH) as model drug. As loperamide hydrochloride is poorly soluble in water it was used in crystalline form with a loading of 2 mg/6 cm(2) film. Hydroxypropyl methylcellulose (HPMC) and different types of hydroxypropyl cellulose (HPC) in different concentrations were used as film forming polymers whereas arabic gum, xanthan gum and tragacanth served as thickening agents. Films were characterized with respect to the content uniformity, morphology, thermal behavior and crystallinity. Suspensions were investigated regarding their viscosity using a rotational rheometer and the crystal structure of the Active Pharmaceutical Ingredient (API) was analyzed using polarized light microscopy. The development of flexible, non-brittle and homogeneous films of LPH was feasible. Two polymorphic forms of LPH appeared in the film formulations dependent on the utilized polymer. While in presence of HPMC the original polymorphic form I remained stable in suspension and films, the polymorphic form II occurred in presence of HPC. Both polymorphic forms were prepared separately and a solid state characterization was performed. Polymorph I showed isometric crystals whereas polymorph II showed needle shaped crystals. Tragacanth was able to prevent the transformation to polymorph II, if it was dissolved first before HPC. When HPC was added first to the suspension, the conversion to form II occurred irreversibly also after further addition of tragacanth. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:52 / 63
页数:12
相关论文
共 34 条
[1]  
[Anonymous], 2004, PROD DAT SHEET KLUC
[2]  
[Anonymous], 2007, USERS MANUAL ERICHSE
[3]   Effects of stabilizers on particle redispersion and dissolution from polymer strip films containing liquid antisolvent precipitated griseofulvin particles [J].
Beck, Christian ;
Sievens-Figueroa, Lucas ;
Gaertner, Konstantin ;
Jerez-Rozo, Jackeline I. ;
Romanach, Rodolfo J. ;
Bilgili, Ecevit ;
Dave, Rajesh N. .
POWDER TECHNOLOGY, 2013, 236 :37-51
[4]  
Bhattacharjee S., 2014, INT J PHARM PHARM SC, V6, P107
[5]  
BURGER A, 1979, MIKROCHIM ACTA, V2, P273
[6]   POLYMORPHISM OF PHARMACEUTICALS AND OTHER MOLECULAR-CRYSTALS .1. THEORY OF THERMODYNAMIC RULES [J].
BURGER, A ;
RAMBERGER, R .
MIKROCHIMICA ACTA, 1979, 2 (3-4) :259-271
[7]   HYDRATION OF DRUG MOLECULES - CAVITY-INCLUSION OF WATER IN CRYSTALS OF LOPERAMIDE HYDROCHLORIDE TETRAHYDRATE [J].
CAIRA, MR ;
GERBER, JJ ;
LOTTER, AP .
SUPRAMOLECULAR CHEMISTRY, 1995, 5 (03) :225-230
[8]   Development and In Vitro-In Vivo Evaluation of Fenretinide-Loaded Oral Mucoadhesive Patches for Site-Specific Chemoprevention of Oral Cancer [J].
Desai, Kashappa-Goud H. ;
Mallery, Susan R. ;
Holpuch, Andrew S. ;
Schwendeman, Steven P. .
PHARMACEUTICAL RESEARCH, 2011, 28 (10) :2599-2609
[9]  
Deutsches Institut fur Normung, 2003, 5273 DIN EN ISO
[10]  
Deutsches Institut fur Normung, 1996, 5271 DIN EN ISO